Efavirenz USP Related Compound B

CAT. No : E180002
CAS. No : 440124-96-9
Mol. F : C14H11ClF3NO2
Mol. Wt : 317.69 g/mol
Synonyms : (E)-Dihydro Efavirenz;Efavirenz Ethene Analog
Chemical Name : (E)-Dihydro Efavirenz
Stock Status : Instock

  • Buy High-Quality Efavirenz USP Related Compound B from Simson Pharma Limited at best competitive price.
  • Every compound produced by Simson Pharma is accompanied by Certificate of Analysis.
Product Applications & Regulatory Search Terms:

Buy 440124-96-9 | Purchase 440124-96-9 | Order 440124-96-9 | Enquire 440124-96-9 | Price of 440124-96-9 | 440124-96-9 Supplier | 440124-96-9 Manufacturer | 440124-96-9 Exporter | Efavirenz USP Related Compound B for Method Validation | Efavirenz USP Related Compound B Reference Standard | Efavirenz USP Related Compound B for ANDA Filing | Efavirenz USP Related Compound B for Forced Degradation Studies | Efavirenz USP Related Compound B Identification Standards | Efavirenz USP Related Compound B for DMF Filing | Buy high quality Efavirenz USP Related Compound B | Purchase Efavirenz USP Related Compound B | Efavirenz USP Related Compound B suppliers | Efavirenz USP Related Compound B manufacturers | Efavirenz USP Related Compound B price | Efavirenz USP Related Compound B exporter | Order Efavirenz USP Related Compound B | Enquire Efavirenz USP Related Compound B | Efavirenz USP Related Compound B cost | Efavirenz USP Related Compound B Supplier | Efavirenz USP Related Compound B Distributor

Please enter your code
wait_ Please wait...

Product Object

Related Products

Discover all
Disclaimer:

The information provided on this webpage is based on the best available knowledge at the time of creation. However, accuracy and completeness are not guaranteed. Product specifications may change without notice, and it is the responsibility of the purchaser, user, or importer of record to verify the accuracy and suitability of the product at the time of ordering.

This product is intended for research use only and is not approved for human consumption.